Two Sigma Investments’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
CCM
VCM
NTCM
Two Sigma Investments's IRMD Position: Q1 2026 in Review
Two Sigma Investments increased its iRadimed (IRMD) stake by 155% in Q1 2026, buying an estimated $10.1M and bringing the position to 165,669 shares worth $15.9M. The position accounts for 0.01% of the portfolio, ranked #1100.
Two Sigma Investments first reported a position in IRMD in Q2 2020 and has held it in 16 quarters since. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.
- Two Sigma Investments held 165,669 shares of iRadimed worth $15.9M as of Q1 2026.
- Two Sigma Investments bought 100,755 iRadimed shares in Q1 2026, an estimated $10.1M.
- iRadimed made up 0.01% of Two Sigma Investments's portfolio in Q1 2026, its #1100 holding.
- Two Sigma Investments first reported a position in iRadimed in Q2 2020 and has held it in 16 quarters since.
- 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.
Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.